Maven Securities’s Insmed INSM Stock Holding History

Maven Securities’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,000	Closed	-$335K	–	981
2024 Q2	$335K	Buy	+5,000	New	+$194K	0.01%	767

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Maven Securities's INSM Position: Q3 2024 in Review

Maven Securities sold out of Insmed (INSM) in Q3 2024, closing a stake of 5,000 shares — an estimated $335K sold.

Maven Securities first reported a position in INSM in Q2 2024 and held it in 1 quarter. The position peaked at $335K in Q2 2024. 413 funds tracked by Wall St. Rank hold INSM as of Q3 2024.

Maven Securities reported no remaining Insmed position as of Q3 2024 after selling out during the quarter.
Maven Securities sold 5,000 Insmed shares in Q3 2024, an estimated $335K.
Maven Securities first reported a position in Insmed in Q2 2024 and held it in 1 quarter.
Maven Securities's Insmed position peaked at $335K in Q2 2024.
413 funds tracked by Wall St. Rank held Insmed as of Q3 2024.

Based on Maven Securities's 13F filing for Q3 2024, filed 14 Nov 2024.